ClinConnect ClinConnect Logo
Search / Trial NCT05599841

Povidone Iodine Irrıgation at Hip-Knee Arthroplasty

Launched by ANKARA UNIVERSITY · Oct 26, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the use of a solution called povidone iodine (PI) during hip and knee replacement surgeries for patients with osteoarthritis. Povidone iodine is a liquid that helps prevent infections, but it contains iodine, which can be absorbed by the body. The researchers want to find out how much iodine is absorbed when this solution is used during these surgeries.

To participate in this trial, you need to be between the ages of 65 and 74 and have osteoarthritis that requires hip or knee surgery. However, if you have any thyroid problems or a history of thyroid disease, you won’t be eligible to join. If you decide to take part, you'll help doctors learn more about how this solution works, and your participation could contribute to improving care for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients with hip/knee osteoarthritis who undergo primary arthroplasty
  • Exclusion Criteria:
  • Patients with abnormal thyroid function tests in the preoperative period, a history of the previous thyroid-related disease.

About Ankara University

Ankara University, a prominent institution in Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with various stakeholders to design and implement studies that address critical health challenges. Leveraging a diverse network of experienced researchers and state-of-the-art facilities, Ankara University aims to contribute significantly to the global medical community by generating valuable insights and fostering the development of effective therapeutic interventions.

Locations

Ankara, , Turkey

Patients applied

0 patients applied

Trial Officials

Hakan Kocaoglu, MD

Principal Investigator

Ankara University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials